Discover how, as part of its new Good Distribution Practice (GDP) compliance solution, pharmaceutical transport specialist transmed Transport turned to ORBCOMM to develop an integrated system for end-to-end real-time temperature management and validation across its warehouses, distribution centers (DCs) and transport fleet…
Headquartered in Regensberg, Germany, transmed Transport GmbH specializes in the distribution of drugs and healthcare products to pharmacies, dispensing doctors, hospitals, medical centers and care homes. transmed is the logistics and transport arm of the PHOENIX Group, Europe’s leading pharmaceutical wholesaler, with annual revenues of EUR23.3bn as at 31/1/16 from operations in 26 countries. Active across West, Central, East and South East Europe, PHOENIX serves around 60,000 customers, supplying up to 140,000 different pharmaceutical items from its network of 153 distribution centers.
In its home market of Germany, transmed operates from three main temperature-controlled warehouse hubs, serving 20 regional DCs. Its fleet of 2,500 vehicles delivers goods around the clock both for its parent company and, more recently, under direct contract to pharmaceutical producers. The fleet ranges from the smallest caddy vehicles for local ‘milk run’ deliveries up to two hours; to mid-range vans up to 2.8 tons for longer-range operations; to temperaturecontrolled vans up to 3.5 tons for the longest distances, including overnight deliveries up to 1,000km and more.
The Challenge (and Opportunity)
In September 2013, the EU introduced its revised Good Distribution Practice (GDP) Guidelines (2013/C 343/01) aimed at maintaining the quality and integrity of medicinal products for human use right along the supply chain from manufacturer to patient.
The updated guidelines recognized the increasingly complex, multi-party nature of modern pharmaceutical distribution networks and sought to provide a new framework for risk management and quality control. In particular, the 2013 Guidelines laid down new rules for transport, to protect medicinal products against breakage, adulteration and theft and, critically, “to ensure that temperature conditions are maintained within acceptable limits during transport.”
“This new stipulation for temperatures to be maintained and validated across the transport chain was a game-changer for pharmaceutical shippers and carriers alike,” says Stefan Butenholz, Regional Manager North for transmed. Read more ›